a pharmaceutical preparation for nasal administration of morphine analgesic or tuimastava reaction and method for induction imetajalVINCENT D. ROMEO SURNUDANTHONY P. SILENOJORGE C. DEMEIRELESCHARANJIT R. BEHLRAJA G. ACHARIRAMNEIK DUA
The method is based upon the stimulation of a localized area of the tracheal submucosa by means of embedded electrodes. 2. Employing this technique, codeine phosphate was found to possess greater antitussive activity than morphine sulfate. The administration of saline was ineffectual in inhibiting ...
Test sample (n)Dose (mg/kg)Time before acetaminophen (min)Route of administrationBlood sampling (min) Control (12) – – – 15, 30, 60, 90 and 120 Morphine (6) 10 15 s.c. 15, 30, 60, 90 and 120 B. trimera (6) 50 30 Gavage 15, 30, 60, 90 and 120 L. alba (6) 50 ...
it is an object of the invention to provide a method for the management of urinary incontinence with oxybutynin and/or its pharmaceutically acceptable salt alone, or in combination with another drug, or preceeded by or followed by the administration of another drug, for the management of inconti...
[0015] Oxycodone is a white, odorless crystalline powder of semi-synthetic origin with multiple actions qualitatively similar to those of morphine. [0015] [0016] The principal actions of therapeutic value are analgesia and sedation. It is similar to codeine and methadone in that it retains at le...
addiction, such as, Buprenorphine, Clonidine, Cydazocine, Dihydroetorphine hydrochloride, and the like. However, some of these medications can easily cause nervous derangement and agitation, others will cause the withdrawal syndrome or the syndrome will appear on stopping the administration of the ...
Although the solvent itself produced marked depression of testosterone levels, probably due to stress on the animals, the further decrease resulting from the administration of test compounds was much more marked for the compounds of the invention than for ketoconazole. The rise in LH levels is ascri...
The present invention relates to a pharmaceutical formulation for intranasal administration comprising morphine or pharmaceutically acceptable salt thereof at a pH from about 3.0 to about 7.0. Such formulations provide enhanced absorption of morphine or pharmaceutically acceptable salts thereof. In one ...
Does the method and timing of ketamine administration effect postoperative morphine requirement?: 14AP4–1Sjogren's syndromesalivary glandsultrasonographysialographysalivary gland scintigraphydiagnosisAn abstract is unavailable.doi:10.1097/00003643-201006121-00643F. Biçer...
MARSHALL, I. & WEINSTOCK, M. (1971). Quantitative method for assessing one symptom of the withdrawal syndrome in mice after chronic morphine administration. Nature, 234, 223 ± 224.Davidson, N. & H. Reisine. Presynaptic inhibition in cuneate blocked by GABA antagonists. Nature New Biology ...